| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Viral Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke,
Experimental Immunology Branch and
Viral Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
Human T lymphotropic virus type I (HTLV-I)-associated
myelopathy/tropical spastic paraparesis (HAM/TSP) is an inflammatory
neurologic disease caused by HTLV-I infection and has been associated
with elevated levels of several proinflammatory cytokines in both serum
and cerebrospinal fluid. It is unknown what kind of cells secrete these
cytokines and if HTLV-I Ags are associated with this phenomenon. Here,
we investigated the expression of cytokines in PBL from eight HAM/TSP
patients, nine HTLV-I-infected asymptomatic carriers, and seven healthy
controls by flow cytometry combined with intracellular cytokine
staining. PBL were cultured with brefeldin A without mitogen and IL-2
for 14 h. Under these conditions, CD8+ cells produced
proinflammatory cytokines including IFN-
, TNF-
, and IL-2, which
were significantly elevated in HAM/TSP patients. The proportion of
CD8+ cells producing IFN- in HAM/TSP patients,
asymptomatic carriers, and healthy controls were, on average, 4.9, 0.4,
and 0.3%, respectively. IFN- production by these CD8+
cells was suppressed by anti-HLA-class I Ab. Purified
CD8+ cells from an HLA-A2 HAM/TSP patient produced IFN-
by cocultivation with autologous CD4 cells, the main reservoir of
HTLV-I in vivo, or allogenic HLA-A2+ B cells pulsed with a
known immunodominant HTLV-I tax peptide. These data suggest that high
levels of circulating HTLV-I-specific CD8+ T lymphocytes
have the potential to produce proinflammatory cytokines and may promote
inflammatory responses to HTLV-I in HAM/TSP
patients.
This article has been cited by other articles:
|
|
 |
|
  S. L. Manuel, T. D. Schell, E. Acheampong, S. Rahman, Z. K. Khan, and P. Jain Presentation of human T cell leukemia virus type 1 (HTLV-1) Tax protein by dendritic cells: the underlying mechanism of HTLV-1-associated neuroinflammatory disease J. Leukoc. Biol., November 1, 2009; 86(5): 1205 - 1216. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kattan, A. MacNamara, A. G. Rowan, H. Nose, A. J. Mosley, Y. Tanaka, G. P. Taylor, B. Asquith, and C. R. M. Bangham The Avidity and Lytic Efficiency of the CTL Response to HTLV-1 J. Immunol., May 1, 2009; 182(9): 5723 - 5729. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Sabouri, K. Usuku, D. Hayashi, S. Izumo, Y. Ohara, M. Osame, and M. Saito Impaired function of human T-lymphotropic virus type 1 (HTLV-1)-specific CD8+ T cells in HTLV-1-associated neurologic disease Blood, September 15, 2008; 112(6): 2411 - 2420. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Enose-Akahata, U. Oh, C. Grant, and S. Jacobson Retrovirally induced CTL degranulation mediated by IL-15 expression and infection of mononuclear phagocytes in patients with HTLV-I-associated neurologic disease Blood, September 15, 2008; 112(6): 2400 - 2410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kozako, N. Arima, S. Toji, I. Masamoto, M. Akimoto, H. Hamada, X.-F. Che, H. Fujiwara, K. Matsushita, M. Tokunaga, et al. Reduced Frequency, Diversity, and Function of Human T Cell Leukemia Virus Type 1-Specific CD8+ T Cell in Adult T Cell Leukemia Patients J. Immunol., October 15, 2006; 177(8): 5718 - 5726. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mitra-Kaushik, J. Harding, J. Hess, R. Schreiber, and L. Ratner Enhanced tumorigenesis in HTLV-1 Tax-transgenic mice deficient in interferon-gamma Blood, November 15, 2004; 104(10): 3305 - 3311. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. E. A. Brito-Melo, J. G. Souza, E. F. Barbosa-Stancioli, A. B. F. Carneiro-Proietti, B. Catalan-Soares, J. G. Ribas, G. W. Thorum, R. D. R. Rocha, O. A. Martins-Filho, and Grupo Interdisciplinar de Pesquisas em HTLV Establishing Phenotypic Features Associated with Morbidity in Human T-Cell Lymphotropic Virus Type 1 Infection Clin. Vaccine Immunol., November 1, 2004; 11(6): 1105 - 1110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Yamano, C. J. Cohen, N. Takenouchi, K. Yao, U. Tomaru, H.-C. Li, Y. Reiter, and S. Jacobson Increased Expression of Human T Lymphocyte Virus Type I (HTLV-I) Tax11-19 Peptide-Human Histocompatibility Leukocyte Antigen A*201 Complexes on CD4+ CD25+ T Cells Detected by Peptide-specific, Major Histocompatibility Complex-restricted Antibodies in Patients with HTLV-I-associated Neurologic Disease J. Exp. Med., May 17, 2004; 199(10): 1367 - 1377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Saito, V. M. Braud, P. Goon, E. Hanon, G. P. Taylor, A. Saito, N. Eiraku, Y. Tanaka, K. Usuku, J. N. Weber, et al. Low frequency of CD94/NKG2A+ T lymphocytes in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriers Blood, July 15, 2003; 102(2): 577 - 584. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kubota, Y. Furukawa, S. Izumo, K. Usuku, and M. Osame Degenerate specificity of HTLV-1-specific CD8+ T cells during viral replication in patients with HTLV-1-associated myelopathy (HAM/TSP) Blood, April 15, 2003; 101(8): 3074 - 3081. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Muraro, K.-P. Wandinger, B. Bielekova, B. Gran, A. Marques, U. Utz, H. F. McFarland, S. Jacobson, and R. Martin Molecular tracking of antigen-specific T cell clones in neurological immune-mediated disorders Brain, January 1, 2002; 126(1): 20 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Hanon, P. Goon, G. P. Taylor, H. Hasegawa, Y. Tanaka, J. N. Weber, and C. R. M. Bangham High production of interferon {gamma} but not interleukin-2 by human T-lymphotropic virus type I-infected peripheral blood mononuclear cells Blood, August 1, 2001; 98(3): 721 - 726. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Saito, G. P. Taylor, A. Saito, Y. Furukawa, K. Usuku, J. N. Weber, M. Osame, and C. R. M. Bangham In Vivo Selection of T-Cell Receptor Junctional Region Sequences by HLA-A2 Human T-Cell Lymphotropic Virus Type 1 Tax11-19 Peptide Complexes J. Virol., January 15, 2001; 75(2): 1065 - 1071. [Abstract] [Full Text]
|
|
|
|
|
|
K. J. M. Jeffery, A. A. Siddiqui, M. Bunce, A. L. Lloyd, A. M. Vine, A. D. Witkover, S. Izumo, K. Usuku, K. I. Welsh, M. Osame, et al. The Influence of HLA Class I Alleles and Heterozygosity on the Outcome of Human T Cell Lymphotropic Virus Type I Infection J. Immunol., December 15, 2000; 165(12): 7278 - 7284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Hanon, S. Hall, G. P. Taylor, M. Saito, R. Davis, Y. Tanaka, K. Usuku, M. Osame, J. N. Weber, and C. R. M. Bangham Abundant Tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes Blood, February 15, 2000; 95(4): 1386 - 1392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Pique, A. Ureta-Vidal, A. Gessain, B. Chancerel, O. Gout, R. Tamouza, F. Agis, and M.-C. Dokhelar Evidence for the Chronic in Vivo Production of Human T Cell Leukemia Virus Type I Rof and Tof Proteins from Cytotoxic T Lymphocytes Directed against Viral Peptides J. Exp. Med., February 7, 2000; 191(3): 567 - 572. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. M. Jeffery, K. Usuku, S. E. Hall, W. Matsumoto, G. P. Taylor, J. Procter, M. Bunce, G. S. Ogg, K. I. Welsh, J. N. Weber, et al. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy PNAS, March 30, 1999; 96(7): 3848 - 3853. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
